TrakCel continues to expand workforce

Cardiff medical software company TrakCel will be increasing their number of staff beyond a hundred as they expand their workforce to meet global demand for their product. Having more than doubled their employee numbers during the financial year, Business News Wales reports TrakCel is set to recruit over forty people in 2019. The company’s recruitment … Continue reading TrakCel continues to expand workforce

TrakCel to build custom configured system for Medeor

TrakCel, a Cardiff-based cell and gene therapy supply chain tracking and orchestration system software developer, has announced it has been engaged to build a custom configured system for Medeor Therapeutics, a clinical stage biotechnology company dedicated to the discovery, development and commercialisation of personalised cellular immunotherapies engineered to reprogramme the immune system in order to … Continue reading TrakCel to build custom configured system for Medeor

TrakCel to supply Northern Alliance

TrakCel has announced it will be the organisation responsible for tracking and documentation of cell and gene therapy products for the Northern Alliance Advanced Therapies Treatment Centre. The Northern Alliance is a partnership of advanced therapies companies, NHS organisations and academic groups in the north of England and Scotland. The partnership of twenty organisations will … Continue reading TrakCel to supply Northern Alliance

£7.3m award brings advanced medical therapies to Wales

A recently formed health consortium, jointly led by the Welsh Blood Service (on behalf of NHS Wales) and the National Institute for Health Research Birmingham Biomedical Research Centre, has been awarded £7.3m of UK Government funding to ensure more people benefit from a new generation of breakthrough therapies. Abertawe Bro Morgannwg University Health Board reports … Continue reading £7.3m award brings advanced medical therapies to Wales

£1.4m awarded to commercialise Rexgenero cell therapy

TrakCel has announced a consortium including itself, the Cell and Gene Therapy Catapult, Rexgenero Ltd and Fisher Bioservices (part of Thermo Fisher Scientific) has secured funding of £1.4m from Innovate UK to lead an industrial research project. The project will focus on and design a cost effective commercial manufacturing strategy for Rexgenero’s novel autologous cell … Continue reading £1.4m awarded to commercialise Rexgenero cell therapy

TrakCel announce partnership with Cell and Gene Therapy Catapult

TrakCel has announced a partnership agreement to incorporate its needle-to-needle supply chain management platform into the Cell and Gene Therapy Catapult’s large scale cell and gene therapy manufacturing centre. The 7,200m² manufacturing centre provides a state of the art GMP facility and support infrastructure to enable collaborators to carry out the large scale manufacture of … Continue reading TrakCel announce partnership with Cell and Gene Therapy Catapult

TrakCel appoints new director

Cardiff-headquartered TrakCel, which develops software for cell and gene therapy companies, has appointed a new director (Insider Media, 2017). Dr Anthony Davies, from Dark Horse Consulting, has been recruited as a non-executive director. He trained as a biochemist, chemical engineer and molecular biologist and has worked in the cell and gene therapy field for more … Continue reading TrakCel appoints new director

TrakCel appoints Joe Vitale as US Director

TrakCel has appointed a new director to support its expansion into the US (Insider Media, 2017). Joe Vitale has been appointed as director of process engineering. He joins from PCT, a Caladrius Company, where he was a senior biomedical engineer. The appointment follows TrakCel’s recent opening of a second US office in New Jersey, led … Continue reading TrakCel appoints Joe Vitale as US Director

Free WordPress Themes, Free Android Games